WithdrawnNCT00781794
Official study titleA Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of Single Oral Doses of NSA-789 on Auditory P50 Suppression in Nonsmoking Patients With Stabilized Schizophrenia
This study was withdrawn before enrollment.
In FranceSchizophreniaMedication studyAges 18–55
- Countries
- France, United States
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
CompletedNCT01796509
Official study titleMulticenter Randomised, Controlled Trial of a Intensive Care Follow -up Programme in Improving Long-term Outcomes of ICU Survivors
This study has finished and is no longer accepting participants.
In FrancePTSDInterventional studyAges 18+
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT05365295
Official study titleSensitivity of Children With Attention Deficit/Hyperactivity Disorder to Memory Error Production
This study has finished and is no longer accepting participants.
In FranceADHDInterventional studyAges 8–11
- Countries
- France
- Sponsor
- University Hospital, Angers
CompletedNCT05268965
Official study titleAutonomic and Subjective Correlates of Affective Forecasting Skills in Post-traumatic Stress Disorder
This study has finished and is no longer accepting participants.
In FrancePTSDObservational studyAges 18–60
- Countries
- France
- Sponsor
- University Hospital, Lille
CompletedNCT06056414
Official study titleStudy of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.
This study has finished and is no longer accepting participants.
In FranceAnxietyInterventional studyAges 18+
- Countries
- France
- Sponsor
- Centre Henri Becquerel
CompletedNCT00257972
What is this study about?This study evaluated the effectiveness of aripiprazole for people with bipolarity.
This study has finished and is no longer accepting participants.
In FranceBipolarityMedication studyAges 18+
- Countries
- France, United States, Australia, + 14 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00861796
What is this study about?Researchers compared CYR-101 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France
- Sponsor
- Cyrenaic Pharmaceuticals
CompletedNCT05216705
Official study titleStudy of Exploratory Plasmatic Markers of Alcohol Withdrawal
This study has finished and is no longer accepting participants.
In FranceAddictionObservational studyAges 18–65
- Countries
- France
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
UnknownNCT03519035
Official study titleStudy of Prevalence and Characteristics of Hallucinations in Patients With Borderline Personality Disorder
Current recruitment status is unconfirmed.
In FrancePersonality disordersObservational studyAges 18–75
- Countries
- France
- Sponsor
- University Hospital, Toulouse